Publications

BibTex format

@article{Wu:2021:10.1183/13993003.04172-2020,
author = {Wu, Y and Wharton, J and Walters, R and Vasilaki, E and Aman, J and Zhao, L and Wilkins, MR and Rhodes, CJ},
doi = {10.1183/13993003.04172-2020},
journal = {European Respiratory Journal},
title = {The pathophysiological role of novel pulmonary arterial hypertension gene SOX17.},
url = {http://dx.doi.org/10.1183/13993003.04172-2020},
volume = {57},
year = {2021}
}

Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Pulmonary arterial hypertension (PAH) is a progressive disease predominantly targeting pre-capillary blood vessels. Adverse structural re-modelling and increased pulmonary vascular resistance result in cardiac hypertrophy and ultimately failure of the right ventricle. Recent whole genome and exome sequencing studies have identified SOX17 as a novel risk gene in PAH, with a dominant mode of inheritance and incomplete penetrance. Rare deleterious variants in the gene and more common variants in upstream enhancer sites have both been associated with the disease and a deficiency of SOX17 expression may predispose to PAH. This review aims to consolidate the evidence linking genetic variants in SOX17 to PAH and explores the numerous targets and effects of the transcription factor, focussing on the pulmonary vasculature and the pathobiology of PAH.
AU  - Wu,Y
AU  - Wharton,J
AU  - Walters,R
AU  - Vasilaki,E
AU  - Aman,J
AU  - Zhao,L
AU  - Wilkins,MR
AU  - Rhodes,CJ
DO  - 10.1183/13993003.04172-2020
PY  - 2021///
SN  - 0903-1936
TI  - The pathophysiological role of novel pulmonary arterial hypertension gene SOX17.
T2  - European Respiratory Journal
UR  - http://dx.doi.org/10.1183/13993003.04172-2020
UR  - https://www.ncbi.nlm.nih.gov/pubmed/33632800
UR  - https://erj.ersjournals.com/content/early/2021/02/11/13993003.04172-2020
UR  - http://hdl.handle.net/10044/1/87252
VL  - 57
ER  -

Download

ProfessorLanZhao

Contact

Location

Summary

Citation

BibTex format

RIS format (EndNote, RefMan)